2025-10-14T17:12:20-05:00 2024-12-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2024-04-30 990991065 DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC DANI 2125883264 485 LEXINGTON AVE FLOOR 24 NEW YORK NY 10017 VINCENT RELLA CHIEF FINANCIAL OFFICER 2125883293 2025-10-07 1 1 WILLIAM EPSTEIN P01307171 2129498700 2024 2025-03-06 01:10:19Z X VINCENT RELLA 485 LEXINGTON AVENUE NEW YORK NY 10017 2229833 0 X WWW.DANIELWOFFITFUND.ORG X 2024 NY DEDICATED TO ADVANCING GLIOBLASTOMA RESEARCH AND THERAPIES. 3 3 0 0 0 0 615339 0 14018 0 629357 0 0 0 0 97425 97425 97425 531932 538884 0 538884 X THE DANIEL W. OFFIT FUND TO FIGHT GLIOBLASTOMA IS DEDICATED TO ADVANCING GLIOBLASTOMA RESEARCH AND THERAPIES. 0 0 THE DANIEL W. OFFIT FUND TO FIGHT GLIOBLASTOMA, INC. (THE ORGANIZATION) PLANS TO FUNDRAISE TO FUND RESEARCH AND THERAPIES FOR CANCER, INCLUDING IN PARTICULAR GLIOBLASTOMA. THE GLIOBLASTOMA MULTIFORME (GBM) IS THE MOST COMMON AND DEADLIEST FORM OF ADULT BRAIN CANCER. TO DATE THERE HAS BEEN LITTLE PROGRESS MADE IN IDENTIFYING A CURE FOR THIS DISEASE, WITH THE AVERAGE LIFE EXPECTANCY AFTER DIAGNOSIS SADLY BEING AROUND 14 MONTHS. (CONTINUED SCHED O)(CONTINUED FROM PAGE 2, PART III, 4A) THE ORGANIZATION INTENDS TO FUNDRAISE FROM THE PUBLIC, INCLUDING THROUGH FUNDRAISING EVENTS, AND ALL OF THE FUNDS RAISED BY THE ORGANIZATION WILL BE USED TO FUND AND ADVANCE FURTHER RESEARCH AND THERAPIES FOR CANCER, INCLUDING IN PARTICULAR GBM.THE ORGANIZATION INTENDS TO HAVE A SCIENTIFIC ADVISORY BOARD (SAB), WHICH WILL BE COMPOSED OF EXPERT MEDICAL AND RESEARCH PROFESSIONALS, TO ADVISE THE ORGANIZATION ON THE PROJECTS THAT HAVE THE MOST VIABLE PATH TO A CURE FOR GBM. THE ORGANIZATION WILL USE THE FEEDBACK OF ITS SAB TO DETERMINE THE MOST IMPORTANT RESEARCH PRIORITIES AND TO SOLICIT AND FUND RESEARCH PROPOSALS AIMED AT ADDRESSING THESE PRIORITIES. THE ORGANIZATION WILL ENSURE THAT ANY GRANTS IT MAKES ARE SELECTED AND DISTRIBUTED THROUGH AN OPEN AND DISINTERESTED PROCESS AND THROUGH EXISTING ACADEMIC AND PROFESSIONAL INFRASTRUCTURES. 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 3 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 NY X VINCENT RELLA 2125883293 485 LEXINGTON AVENUE NEW YORK NY 10017 X MORRIS OFFIT DIRECTOR 2.00 0.00 X 0 0 0 NED OFFIT PRESIDENT 2.00 0.00 X X 0 0 0 VINCENT RELLA SECRETARY/TREASURER 2.00 0.00 X X 0 0 0 0 0 0 0 0 0 0 0 615339 48316 615339 14001 14001 1600493 1600476 17 17 17 629357 0 0 14018 VENUE RENTAL 90650 90650 MISCELLANEOUS 6775 6775 97425 0 0 97425 0 1 0 7034 0 531849 0 538884 0 0 X 0 538884 0 538884 0 538884 531932 6952 0 X 1 X 0 0 0 X 615339 615339 615339 615339 242833 372506 14001 14001 629340 X FORM 990, SCHEDULE A, PART II, LINE 13 THE YEAR ENDING DECEMBER 31, 2024 WAS THE ORGANIZATION'S INITIAL YEAR OF EXISTENCE AND WAS A SHORT YEAR WITH A PERIOD OF APRIL 30, 2024 THROUGH DECEMBER 31, 2024. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 48316 SIMILAR SALES 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 FAMILY AND BUSINESS RELATIONSHIPS BETWEEN BOARD MEMBERS AND OFFICER: MORRIS OFFIT, NED OFFIT AND VINCENT RELLA. FORM 990, PART VI, SECTION B, LINE 11B REVIEW OF FORM 990: THE BOARD OF DIRECTORS REVIEWS THE FORM 990 PRIOR TO ITS ELECTRONIC FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C MONITORING AND ENFORCEMENT OF CONFLICT OF INTEREST POLICY: BOARD MEMBERS ARE REQUIRED TO DISCLOSE ANNUALLY ANY RELATIONSHIPS, PERSONAL OR BUSINESS, WITH THE FUND AND ANY OTHER RELATED ENTITY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS: ALL GOVERNING DOCUMENTS AND FORMS THAT ARE REQUIRED FOR PUBLIC VIEWING ARE AVAILABLE FROM THE ORGANIZATION UPON REQUEST.